University of Thessaly (UTH)
Διερεύνηση βιοδεικτών επί των ασθενών με καρδιακή ανεπάρκεια
Abstract
dc:descriptionThe prognosis and progression of heart failure (HF) is studied in the recent years with the use of specific biomarkers (BMRs). Aim: To assess the prognostic value of simple and novel BMRs which are measured in the blood of patients with systolic HF, and to correlate their levels and fluctuations with the clinical status, quality of life, 6-minute walking test (6MWT), electrocardiographic (ECG) and echocardiographic findings. Methods: 61 patients (49 men) who were hospitalized in the 1st Cardiology department of the General Hospital in Nikea – Piraeus ‘St. Panteleimon’, with symptoms of HF and left ventricular (LV) ejection fraction ≤35% were enrolled in this study. Patients were followed up for 1 year. Exclusion criteria were renal disease worse than stage 3, primary liver disease, autoimmune disease, cancer, congenital heart disease and severe valvular heart disease other than severe functional mitral regurgitation. The novel BMRs studied were: N-terminal pro-brain natriuretic peptide (NT-proBNP), galectin-3 (Gal-3), cystatin C (CysC), soluble suppression of tumorgenicity 2 (sST2), growth-differentiation factor-15 (GDF-15), prolactin, osteopontin, interleukin-1β and high sensitivity C-reactive protein. Moreover, the prognostic value of simple BMRs, such as uric acid, lipoproteins, and free triiodothyronine (fT3) was also investigated. Measurements of novel BMRs were conducted in the Biomedical Research Foundation of the Academy of Athens. P-value <0.05 was considered significant. Results: Baseline New York Heart Association (NYHA) clinical status of HF was significantly correlated with NT-proBNP (p < 0.0001), GDF-15 (p = 0.005), total cholesterol (p = 0.014), alanine aminotransferase (SGPT) (p = 0.009), and uric acid (p = 0.024). Significant predictors of 6MWT proven were: total cholesterol (p < 0.001), low density lipoprotein (LDL) (p = 0.006), high density lipoprotein (HDL) (p = 0.008), aspartate aminotransferase (SGOT) (p = 0.028), NT-proBNP (p = 0.001), sST2 (p = 0.009), GDF-15 (p = 0.03) and Gal-3 (p = 0.016). Greater dilatation of LV and lower fT3 were correlated with wider QRS interval on the ECG (p < 0.05). Furthermore, left atrial volume was associated with worse mitral regurgitation (p = 0.032), higher level of CysC (p = 0.019) and higher right ventricular systolic pressure (p = 0.038) in stepwise multiple linear regression analysis. Higher levels of NT-proBNP (>819.4 pg/ml), sST2 (>3.923 ng/ml), Gal-3 (>10.8 ng/ml) και GDF-15 (>2506.35 pg/ml) predicted worse 1-year survival, even after adjustment for age, sex, creatinine clearance, presence of coronary artery disease and diabetes. The addition of sST2, Gal-3 and GDF-15 in the model, improved the predictive value of NT-proBNP alone. Conclusions: Novel BMRs are associated with symptoms’ severity, functional status, and may add additional information for prognosis of patients with systolic HF.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zivlas, Christos
- Ζίβλας, Χρήστος
Subjects
dc:subject × 32- Καρδιακή ανεπάρκεια
- Βιοδείκτης
- Πρόγνωση
- Αριστερός κόλπος
- Δοκιμασία βάδισης 6 λεπτών
- Αμινοτελικό άκρο του πρόδρομου εγκεφαλικού νατριουρητικού πεπτιδίου
- Γκαλεκτίνη-3
- Κυστατίνη C
- Διαλυτός υποδοχέας της ιντερλευκίνης-33
- Αυξητικός παράγοντας διαφοροποίησης-15
- Προλακτίνη
- Οστεοποντίνη
- Ιντερλευκίνη-1Β
- Heart failure
- Biomarker
- Prognosis
- Left atrium
- 6-minute walk test
- N-terminal pro-brain natriuretic peptide
- Galectin-3
- Cystatin C
- Soluble suppression of tumorgenicity 2
- Growth-differentiation factor-15
- Prolactin
- Osteopontin
- Interleukin-1β
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45084